IP Library Granted Patent US 10,100,198
Granted Patent B2
US 10,100,198 · App. 15/258,283 · Granted Oct 16, 2018

Application of reduced dyes in imaging

Inventors: Kousik Kundu (Lincoln, NE); Nisha Padhye (Lincoln, NE); William Volcheck (Lincoln, NE)
Assignee: LI-COR, INC.
C09B23/164C07D209/08C09B23/0008C09B23/0025C09B23/0066C09B23/083C09B23/086C09B23/107G01N33/574G01N33/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,100,198
App. No.
15/258,283
Granted
Oct 16, 2018
Kind
B2
Abstract

The present invention provides novel compounds and methods for hydrocyanines derived from near-infrared cyanine dyes, as reactive oxygen species probes in imaging. In certain embodiments, the present invention provides reduced dyes as substrates for ELISA and Western blots.

Claims (22)

1. A compound, wherein the compound has the formula:

wherein R 1′ and R 1a′ are each independently hydrogen or deuterium;

M is an alkali metal cation; and

R 2 is CO 2 H or CO 2 M.

2. An assay method for measuring an analyte in a sample, the method comprising:

a) contacting said sample with a binding reagent that binds to an analyte to form an analyte complex;

b) contacting said sample with a compound of claim 1 , wherein said compound reacts with a radical, wherein said radical is generated from said analyte complex to form a detectable agent, which said detectable agent is a cyanine dye; and

c) upon excitation, detecting said detectable agent.

3. The method of claim 2 , wherein said analyte is a biological molecule.

4. The method of claim 2 , wherein said binding reagent is an antibody.

5. The method of claim 2 , wherein said analyte complex comprises an enzyme wherein a substrate of the enzyme is hydrogen peroxide.

6. The method of claim 2 , wherein said detectable agent is an oxidized form of a compound of claim 1 .

7. The method of claim 2 , wherein said assay method is an immunological detection method.

8. The method of claim 7 , wherein said immunological detection method is a member selected from the group consisting of an enzyme linked immunosorbent assay (ELISA), a Western blot analysis, and an immunohistochemical analysis.

9. A method for detecting a reactive oxygen species in a cell of a sample or a subject, said method comprising:

contacting a cell with one or more compounds of claim 1 , to form an oxidized form of said compound; and

exciting the oxidized form of said compound to emit light.

10. The method of claim 9 , wherein the oxidized form of said compound is detected by a method selected from the group consisting fluorescence spectroscopy or fluorescence microscopy.

11. A kit for conducting a fluorescent assay, said kit comprising a composition, said composition comprising:

a) a compound of claim 1 ; and

b) a buffer.

12. The kit of claim 11 , further comprising instructions for use of the composition in the fluorescent assay.

Assignments (2)
SECURITY INTEREST Recorded Dec 1, 2021
From: LI-COR, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 058293/0889 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2016
From: KUNDU, KOUSIK; PADHYE, NISHA; VOLCHECK, WILLIAM
To: LI-COR, INC.
Reel/Frame 039659/0326 →
Continuity (6)
Division 14192827 · Feb 27, 2014
Continuation PCTUS2012056739 · Sep 21, 2012
Provisional Application 61597677 · Feb 10, 2012
Provisional Application 61570772 · Dec 14, 2011
Provisional Application 61538771 · Sep 23, 2011
Related Publication 20170130050A1 · May 11, 2017
Cited By (2)
US 12,305,217 US 12,492,422